CA3135225A1 - Dispositifs et procedes de traitement d'deme - Google Patents
Dispositifs et procedes de traitement d'deme Download PDFInfo
- Publication number
- CA3135225A1 CA3135225A1 CA3135225A CA3135225A CA3135225A1 CA 3135225 A1 CA3135225 A1 CA 3135225A1 CA 3135225 A CA3135225 A CA 3135225A CA 3135225 A CA3135225 A CA 3135225A CA 3135225 A1 CA3135225 A1 CA 3135225A1
- Authority
- CA
- Canada
- Prior art keywords
- impeller
- catheter
- expandable member
- proximal
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 100
- 206010030113 Oedema Diseases 0.000 title claims abstract description 62
- 239000012530 fluid Substances 0.000 claims abstract description 104
- 230000001926 lymphatic effect Effects 0.000 claims abstract description 47
- 230000007423 decrease Effects 0.000 claims abstract description 24
- 210000004369 blood Anatomy 0.000 claims description 85
- 239000008280 blood Substances 0.000 claims description 85
- 210000003129 brachiocephalic vein Anatomy 0.000 claims description 46
- 239000012528 membrane Substances 0.000 claims description 15
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 239000002184 metal Substances 0.000 claims description 14
- 230000007704 transition Effects 0.000 claims description 14
- 238000003780 insertion Methods 0.000 claims description 10
- 230000037431 insertion Effects 0.000 claims description 10
- 239000000853 adhesive Substances 0.000 claims description 7
- 230000001070 adhesive effect Effects 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 238000005259 measurement Methods 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 abstract description 22
- 238000011282 treatment Methods 0.000 abstract description 22
- 210000004324 lymphatic system Anatomy 0.000 abstract description 14
- 238000010926 purge Methods 0.000 description 59
- 239000003146 anticoagulant agent Substances 0.000 description 42
- 229940127219 anticoagulant drug Drugs 0.000 description 42
- 239000000463 material Substances 0.000 description 36
- 210000004731 jugular vein Anatomy 0.000 description 32
- 210000004204 blood vessel Anatomy 0.000 description 25
- 230000007246 mechanism Effects 0.000 description 25
- 239000003814 drug Substances 0.000 description 20
- 210000002751 lymph Anatomy 0.000 description 17
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 16
- 239000004810 polytetrafluoroethylene Substances 0.000 description 16
- 206010019280 Heart failures Diseases 0.000 description 15
- 230000036961 partial effect Effects 0.000 description 15
- 210000001124 body fluid Anatomy 0.000 description 14
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 12
- 210000003462 vein Anatomy 0.000 description 12
- 206010007559 Cardiac failure congestive Diseases 0.000 description 11
- 238000004891 communication Methods 0.000 description 11
- -1 polytetrafluoroethylene Polymers 0.000 description 11
- 206010053567 Coagulopathies Diseases 0.000 description 9
- 208000007536 Thrombosis Diseases 0.000 description 9
- 230000035602 clotting Effects 0.000 description 9
- 229960002897 heparin Drugs 0.000 description 9
- 229920000669 heparin Polymers 0.000 description 9
- 238000011144 upstream manufacturing Methods 0.000 description 9
- 210000005166 vasculature Anatomy 0.000 description 9
- 206010018910 Haemolysis Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000008588 hemolysis Effects 0.000 description 8
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 239000000306 component Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000001125 extrusion Methods 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000002706 hydrostatic effect Effects 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 229920002614 Polyether block amide Polymers 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- QNZCBYKSOIHPEH-UHFFFAOYSA-N Apixaban Chemical compound C1=CC(OC)=CC=C1N1C(C(=O)N(CC2)C=3C=CC(=CC=3)N3C(CCCC3)=O)=C2C(C(N)=O)=N1 QNZCBYKSOIHPEH-UHFFFAOYSA-N 0.000 description 3
- HGVDHZBSSITLCT-JLJPHGGASA-N Edoxaban Chemical compound N([C@H]1CC[C@@H](C[C@H]1NC(=O)C=1SC=2CN(C)CCC=2N=1)C(=O)N(C)C)C(=O)C(=O)NC1=CC=C(Cl)C=N1 HGVDHZBSSITLCT-JLJPHGGASA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 229960003886 apixaban Drugs 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 229960003850 dabigatran Drugs 0.000 description 3
- YBSJFWOBGCMAKL-UHFFFAOYSA-N dabigatran Chemical compound N=1C2=CC(C(=O)N(CCC(O)=O)C=3N=CC=CC=3)=CC=C2N(C)C=1CNC1=CC=C(C(N)=N)C=C1 YBSJFWOBGCMAKL-UHFFFAOYSA-N 0.000 description 3
- 229960000622 edoxaban Drugs 0.000 description 3
- 229960000610 enoxaparin Drugs 0.000 description 3
- KANJSNBRCNMZMV-ABRZTLGGSA-N fondaparinux Chemical compound O[C@@H]1[C@@H](NS(O)(=O)=O)[C@@H](OC)O[C@H](COS(O)(=O)=O)[C@H]1O[C@H]1[C@H](OS(O)(=O)=O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O4)NS(O)(=O)=O)[C@H](O3)C(O)=O)O)[C@@H](COS(O)(=O)=O)O2)NS(O)(=O)=O)[C@H](C(O)=O)O1 KANJSNBRCNMZMV-ABRZTLGGSA-N 0.000 description 3
- 229960001318 fondaparinux Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920002530 polyetherether ketone Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229960001148 rivaroxaban Drugs 0.000 description 3
- KGFYHTZWPPHNLQ-AWEZNQCLSA-N rivaroxaban Chemical compound S1C(Cl)=CC=C1C(=O)NC[C@@H]1OC(=O)N(C=2C=CC(=CC=2)N2C(COCC2)=O)C1 KGFYHTZWPPHNLQ-AWEZNQCLSA-N 0.000 description 3
- 210000001321 subclavian vein Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000002978 thoracic duct Anatomy 0.000 description 3
- 229960005080 warfarin Drugs 0.000 description 3
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 3
- 206010007556 Cardiac failure acute Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004697 Polyetherimide Substances 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 230000004941 influx Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 229920001601 polyetherimide Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- COKMIXFXJJXBQG-NRFANRHFSA-N tirofiban Chemical compound C1=CC(C[C@H](NS(=O)(=O)CCCC)C(O)=O)=CC=C1OCCCCC1CCNCC1 COKMIXFXJJXBQG-NRFANRHFSA-N 0.000 description 2
- 229960003425 tirofiban Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000339 Marlex Polymers 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241001408665 Timandra griseata Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 210000001308 heart ventricle Anatomy 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/802—Constructional details other than related to driving of non-positive displacement blood pumps
- A61M60/81—Pump housings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/13—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel by means of a catheter allowing explantation, e.g. catheter pumps temporarily introduced via the vascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/403—Details relating to driving for non-positive displacement blood pumps
- A61M60/408—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable
- A61M60/411—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable generated by an electromotor
- A61M60/414—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable generated by an electromotor transmitted by a rotating cable, e.g. for blood pumps mounted on a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/802—Constructional details other than related to driving of non-positive displacement blood pumps
- A61M60/833—Occluders for preventing backflow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0405—Lymph
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Mechanical Engineering (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- External Artificial Organs (AREA)
Abstract
L'invention concerne des dispositifs et des procédés de traitement d'un dème qui utilise une pompe comprenant un ballonnet qui peut être monté sur le boîtier de la pompe. L'invention concerne des dispositifs et des procédés de traitement d'un dème qui utilisent un cathéter à demeure avec une pompe, afin d'abaisser la pression au niveau d'une sortie d'un conduit lymphatique, et un ballonnet autour de la pompe pour guider et restreindre le flux sanguin. Le ballonnet limite l'écoulement de retour provenant de la jugulaire et guide cet écoulement dans la cage de la pompe. En concentrant l'écoulement dans la cage de la pompe, il est possible d'augmenter la vitesse d'écoulement vers le bas du vaisseau, ce qui produit une diminution de pression latérale affectant la sortie lymphatique. Du fait que la sortie lymphatique est soumise à une diminution de pression, des fluides dans le système lymphatique sont drainés vers la sortie et dans le système circulatoire.
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810658P | 2019-02-26 | 2019-02-26 | |
| US201962810653P | 2019-02-26 | 2019-02-26 | |
| US201962810672P | 2019-02-26 | 2019-02-26 | |
| US201962810668P | 2019-02-26 | 2019-02-26 | |
| US201962810660P | 2019-02-26 | 2019-02-26 | |
| US62/810,668 | 2019-02-26 | ||
| US62/810,672 | 2019-02-26 | ||
| US62/810,653 | 2019-02-26 | ||
| US62/810,660 | 2019-02-26 | ||
| US62/810,658 | 2019-02-26 | ||
| PCT/IB2020/000184 WO2020174285A2 (fr) | 2019-02-26 | 2020-02-26 | Dispositifs et procédés de traitement d'œdème |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3135225A1 true CA3135225A1 (fr) | 2020-09-03 |
Family
ID=72239237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3135225A Pending CA3135225A1 (fr) | 2019-02-26 | 2020-02-26 | Dispositifs et procedes de traitement d'deme |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3930600A4 (fr) |
| JP (1) | JP2022523205A (fr) |
| CN (1) | CN113727752A (fr) |
| AU (1) | AU2020230048A1 (fr) |
| CA (1) | CA3135225A1 (fr) |
| IL (1) | IL285734A (fr) |
| WO (1) | WO2020174285A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9901722B2 (en) | 2014-06-01 | 2018-02-27 | White Swell Medical Ltd | System and method for treatment of pulmonary edema |
| EP4252824A3 (fr) | 2017-03-02 | 2023-11-08 | White Swell Medical Ltd | Systèmes et méthodes de réduction de la pression au niveau d'un écoulement de sortie d'un conduit |
| US11793996B2 (en) | 2019-02-26 | 2023-10-24 | White Swell Medical Ltd | Devices and methods for treating edema |
| US11660426B2 (en) | 2019-02-26 | 2023-05-30 | White Swell Medical Ltd | Devices and methods for treating edema |
| US11717652B2 (en) | 2019-02-26 | 2023-08-08 | White Swell Medical Ltd | Devices and methods for treating edema |
| US11931560B2 (en) | 2019-02-26 | 2024-03-19 | White Swell Medical Ltd | Devices and methods for treating edema |
| US11724095B2 (en) | 2019-02-26 | 2023-08-15 | White Swell Medical Ltd | Devices and methods for treating edema |
| WO2021250464A1 (fr) * | 2020-06-08 | 2021-12-16 | White Swell Medical Ltd | Dispositifs non thrombogènes pour le traitement d'un œdème |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071273A (en) * | 1988-02-29 | 2000-06-06 | Scimed Life Systems, Inc. | Fixed wire dilatation balloon catheter |
| US5092844A (en) * | 1990-04-10 | 1992-03-03 | Mayo Foundation For Medical Education And Research | Intracatheter perfusion pump apparatus and method |
| US5643172A (en) * | 1995-03-06 | 1997-07-01 | Abiomed R & D, Inc. | Tubular circulatory assist device |
| DE19622335C2 (de) * | 1996-06-04 | 1999-03-18 | Voelker Wolfram Priv Doz Dr Me | Ballonkatheter |
| US6299596B1 (en) * | 1998-03-20 | 2001-10-09 | Schneider (Usa) Inc. | Method of bonding polymers and medical devices comprising materials bonded by said method |
| AU2017353938B2 (en) * | 2016-11-01 | 2022-10-20 | White Swell Medical Ltd | Systems and methods for treatment of fluid overload |
| DK3398626T3 (da) * | 2017-05-04 | 2021-03-22 | Abiomed Europe Gmbh | Intravaskulær blodpumpe med ballon |
| US11724095B2 (en) * | 2019-02-26 | 2023-08-15 | White Swell Medical Ltd | Devices and methods for treating edema |
-
2020
- 2020-02-26 CA CA3135225A patent/CA3135225A1/fr active Pending
- 2020-02-26 WO PCT/IB2020/000184 patent/WO2020174285A2/fr unknown
- 2020-02-26 EP EP20763700.0A patent/EP3930600A4/fr active Pending
- 2020-02-26 CN CN202080031482.0A patent/CN113727752A/zh active Pending
- 2020-02-26 JP JP2021549632A patent/JP2022523205A/ja active Pending
- 2020-02-26 AU AU2020230048A patent/AU2020230048A1/en active Pending
-
2021
- 2021-08-19 IL IL285734A patent/IL285734A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3930600A4 (fr) | 2022-11-09 |
| IL285734A (en) | 2021-10-31 |
| EP3930600A2 (fr) | 2022-01-05 |
| AU2020230048A1 (en) | 2021-09-23 |
| CN113727752A (zh) | 2021-11-30 |
| JP2022523205A (ja) | 2022-04-21 |
| WO2020174285A2 (fr) | 2020-09-03 |
| WO2020174285A3 (fr) | 2021-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11931560B2 (en) | Devices and methods for treating edema | |
| US11660426B2 (en) | Devices and methods for treating edema | |
| US11724095B2 (en) | Devices and methods for treating edema | |
| US11793996B2 (en) | Devices and methods for treating edema | |
| US11717652B2 (en) | Devices and methods for treating edema | |
| CA3135225A1 (fr) | Dispositifs et procedes de traitement d'deme | |
| US20240058595A1 (en) | Systems and methods for reducing pressure at an outflow of a duct | |
| US6592567B1 (en) | Kidney perfusion catheter | |
| US7374560B2 (en) | Emboli protection devices and related methods of use | |
| WO2017159849A1 (fr) | Pompe à cathéter et procédé de traitement | |
| US20090069829A1 (en) | Rotational Atherectomy Device with Distal Protection Capability and Method of Use | |
| US20220104827A1 (en) | Flow restricting intravascular devices for treating edema | |
| JP2002535091A (ja) | 縮んだ位置でシールされるポートを備えたインペラ血液ポンプ。 | |
| US20220249830A1 (en) | Percutaneous Blood Pump Systems and Related Methods | |
| US20240173464A1 (en) | Distal Flow Arterial Cannula with Expandable Positioning Balloon | |
| US20230211142A1 (en) | Filter for particles in catheter pump system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20231109 |
|
| EEER | Examination request |
Effective date: 20231109 |